Malignant neoplasm of brain, including Hilmo

C3_BRAIN_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C71 Hospital discharge: ICD-9 — 191 Hospital discharge: ICD-8 — 191 Cause of death: ICD-10 — C71 Cause of death: ICD-9 — 191 Cause of death: ICD-8 — 191 Cancer registry: Topography ICD-O-3 — C71 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	2072
4. Check minimum number of events None	2072
5. Include endpoints None	2072
6. Filter based on genotype QC (FinnGen only)	1987

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BRAIN_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C71
HD_ICD_9	191
HD_ICD_8	191
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C71
COD_ICD_9	191
COD_ICD_8	191
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C71
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of brain, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1987	895	1092
Unadjusted period prevalence (%)	0.42	0.32	0.50
Median age at first event (years)	59.49	56.30	62.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2072: Matched controls
20720

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ZXC40

NOMESCO Finland

Use of ultrasound

72.5

319.3

173

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

185.1

307.7

170

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

57.5

307.7

288

A04AA02

ATC

granisetron; systemic, transdermal

1150.7

307.7

582

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

30.8

307.7

395

157

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

602.2

307.7

536

A04AA01

ATC

ondansetron; systemic, rectal

29.3

307.7

480

211

ZXC95

NOMESCO Finland

Use of surgical navigator

68.6

307.7

391

WF003

NOMESCO Finland

Adjuvant radiotherapy

4368.7

307.7

373

XX3DW

NOMESCO Finland

Time consuming IT work

17.1

307.7

526

405

N03AX18

ATC

lacosamide; systemic

70.9

307.7

222

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

534.2

307.7

319

A03FA01

ATC

metoclopramide; systemic, rectal

13.5

307.7

977

1285

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

33.8

307.7

1125

703

AA1AD

NOMESCO Finland

CT of head and brain

5.4

307.7

1093

3530

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

1051

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

482.2

307.7

328

H02AB02

ATC

dexamethasone; systemic

416.0

307.7

1376

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

307.7

398

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

30.3

307.7

500

215

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

30.2

307.7

881

495

WF002

NOMESCO Finland

Radical radiotherapy

549.1

307.7

561

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

307.7

413

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

60.9

307.7

616

143

L01AX03

ATC

temozolomide; systemic

+∞

307.7

807

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

782.7

307.7

1007

Z51.5

ICD-10 Finland

Palliative care

29.1

307.7

550

254

N03AF02

ATC

oxcarbazepine; oral

15.7

307.7

387

298

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

35.7

307.7

393

135

N03AX14

ATC

levetiracetam; systemic

68.5

307.7

809

192

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

+∞

304.9

285

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3034.6

292.6

276

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

1032.2

282.0

270

R56.8

ICD-10 Finland

Other and unspecified convulsions

9.0

277.9

379

502

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

17.9

277.3

232

145

AA1BD

NOMESCO Finland

Extensive CT of head and brain

19.7

264.0

210

118

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

261.1

245

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

+∞

252.4

237

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

+∞

251.3

236

G40.9

ICD-10 Finland

Epilepsy, unspecified

10.4

246.1

291

319

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

+∞

243.7

229

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

444.0

242.2

238

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

+∞

241.5

227

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

32.7

229.6

149

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

+∞

228.5

215

XA800

NOMESCO Finland

Neuropsychological investigation

8.6

228.1

318

429

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.8

220.4

653

1815

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

212.2

200

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

27.0

211.1

146

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

747.5

209.4

203

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.7

205.3

446

949

G40.10

ICD-10 Finland

Simple partial seizures

36.3

195.8

123

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

522.7

194.9

191

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

504.6

188.4

185

N03AB02

ATC

phenytoin; systemic

18.9

187.1

150

WX882

NOMESCO Finland

High dependency care

10.3

185.8

217

232

JN4BD

NOMESCO Finland

Extensive body CT

7.9

182.7

268

381

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

+∞

178.8

169

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

177.7

168

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

+∞

175.6

166

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

25.1

173.5

123

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

168.0

159

N02AA05

ATC

oxycodone; systemic

4.4

166.7

508

1415

ZX050

NOMESCO Finland

Stereotactic radiotherapy

350.0

160.3

160

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

11.9

159.5

167

152

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

1583.6

150.9

145

ZXE20

NOMESCO Finland

More than three and less than five hours

4.3

148.7

457

1273

WZC00

NOMESCO Finland

Treatment plan or consultation

3.3

148.3

873

3738

N05BA09

ATC

clobazam; oral

27.0

142.4

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

18.4

142.2

115

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

140.2

133

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

18.9

139.0

111

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

12.9

137.3

135

111

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

28.8

135.2

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

134.9

128

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

6.0

133.0

256

479

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

+∞

131.7

125

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

+∞

130.6

124

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

+∞

127.4

121

WX402

NOMESCO Finland

General anaesthesia

3.4

122.9

558

2007

ZX090

NOMESCO Finland

Other technic of radiotherapy

221.5

122.1

125

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

215.9

119.0

122

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

+∞

118.9

113

N05CD08

ATC

midazolam; nasal, systemic

8.8

118.8

154

187

JN4AD

NOMESCO Finland

Body CT examination

5.8

118.5

232

440

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

612.0

118.3

116

WF049

NOMESCO Finland

Radiotherapy of metastasis

612.0

118.3

116

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

112.5

107

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

22.4

111.1

N74

ICPC

Malignant neoplasm nervous system

572.8

110.9

109

ZX070

NOMESCO Finland

Intensity modified radiotherapy

572.8

110.9

109

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

+∞

110.4

105

H02AB09

ATC

hydrocortisone; systemic

9.2

110.4

138

160

WZC30

NOMESCO Finland

Teaching

3.7

108.3

403

1266

H53.4

ICD-10 Finland

Visual field defects

9.2

107.3

134

155

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

+∞

107.2

102

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

10.4

105.8

120

122

G91.1

ICD-10 Finland

Obstructive hydrocephalus

27.6

105.6

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

13.7

103.8

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

142.3

102.1

108

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

+∞

100.9

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

+∞

100.9

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

+∞

99.8

AAA10

NOMESCO Finland

Biopsy through craniotomy

511.7

99.4

L03AA02

ATC

filgrastim; parenteral

124.1

99.0

106

N03AF01

ATC

carbamazepine; oral, rectal

5.0

95.8

222

487

WX408

NOMESCO Finland

General anesthesy, balanced

2.8

95.3

630

2762

ZXE30

NOMESCO Finland

More than five and less than seven hours

6.1

95.2

173

304

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

132.6

94.9

101

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

203.4

94.2

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

+∞

92.4

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

+∞

90.3

A02BC02

ATC

pantoprazole; systemic

2.7

89.6

1506

10246

183

Kela drug reimbursment

Lamotrigin and topiramate

14.5

89.0

C61

ICD-10 Finland

Malignant neoplasm of prostate

451.3

87.8

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

+∞

87.1

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.0

86.6

488

1951

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

+∞

85.0

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

46.6

84.8

N03AG01

ATC

valproic acid; systemic, rectal

4.2

82.7

242

636

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

17.3

80.9

115

Kela drug reimbursment

Breast cancer

+∞

80.8

R4150

NOMESCO Finland

Neuropsychological rehabilitation

15.1

78.7

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

+∞

78.6

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

78.6

WW500

NOMESCO Finland

Blood transfusion

8.0

78.6

109

143

A79

ICPC

Malignancy NOS

396.9

77.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

30.1

75.5

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

9.6

74.9

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

32.7

74.3

ZXM40

NOMESCO Finland

Use of fluorescent substance

194.4

72.6

L03AA13

ATC

pegfilgrastim; parenteral

252.1

71.8

8000/3-C71.9

ICD-O-3

Neoplasm, malignant of brain, NOS

+∞

70.2

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

+∞

70.2

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

22.7

69.6

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

+∞

69.1

WX872

NOMESCO Finland

Intensive care

4.2

68.9

194

494

R4110

NOMESCO Finland

Physiotherapy

2.4

68.4

634

3198

C71.60

ICD-10 Finland

Malignant tumor of cerebellum without histology

+∞

68.1

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

67.0

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

67.0

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

7.2

66.0

100

145

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

64.9

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

64.9

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

63.4

455

2029

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

+∞

61.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

9.4

61.6

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

+∞

60.7

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

60.7

G41.9

ICD-10 Finland

Status epilepticus, unspecified

15.7

59.8

A28

ICPC

Limited function/disability NOS

2.6

59.3

435

1955

TAB00

NOMESCO Finland

Lumbar puncture

4.3

59.2

160

394

N76

ICPC

Neoplasm nervous system unspecified

129.9

59.2

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

21.9

57.9

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

57.6

PJA12

NOMESCO Finland

Sentinel node biopsy

300.2

57.6

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

125.6

57.1

R4120

NOMESCO Finland

Occupational therapy

3.5

56.3

207

633

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

18.4

56.1

JN4CD

NOMESCO Finland

Very extensive body CT

9.1

56.0

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

289.1

55.5

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

+∞

55.5

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

9.0

54.6

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

11.5

52.8

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

531.1

52.7

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

+∞

52.3

G40.89

ICD-10 Finland

Other epilepsy

16.6

52.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

51.6

405

1867

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

+∞

50.2

C71.93

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade IV glioma

+∞

50.2

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

+∞

50.2

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

+∞

50.2

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

49.2

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

48.9

749

4507

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

489.0

48.6

B01AB10

ATC

tinzaparin; parenteral

3.2

48.4

204

678

XX2RW, ,

NOMESCO Finland

16.1

47.8

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

+∞

47.1

N05CF01

ATC

zopiclone; oral

2.0

46.7

708

4230

A04AA55

ATC

palonosetron, combinations; systemic

+∞

46.0

Z51.0

ICD-10 Finland

Radiotherapy session

457.5

45.4

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

+∞

45.0

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

44.5

788

4951

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

43.9

C71.43

ICD-10 Finland

Malignant tumor of the occipital lobe grade IV glioma

+∞

43.9

Z2445

NOMESCO Finland

Psychologist

3.8

43.7

137

375

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

436.5

43.3

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.1

43.1

129

A98

ICPC

Health maint/preventive medicine

0.5

42.6

1569

17993

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

42.2

462

2431

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

9.5

41.9

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

41.8

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

41.8

HAB40

NOMESCO Finland

Wedge excision of mammary gland

15.9

41.8

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

55.7

41.6

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

92.0

40.9

116

Kela drug reimbursment

Prostate cancer

+∞

40.8

WX704

NOMESCO Finland

Intubation

3.0

40.6

192

681

L02AE02

ATC

leuprorelin; implant, parenteral

11.6

40.5

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

394.7

39.2

WW300

NOMESCO Finland

Transfer of autologic stem cells

394.7

39.2

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

8.0

38.8

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

38.3

234

950

R47.0

ICD-10 Finland

Dysphasia and aphasia

6.8

37.9

E23.00

ICD-10 Finland

Panhypopituitarism

14.4

37.4

101

Kela drug reimbursment

Anterior pituitary hypofunction

9.0

37.3

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

7.4

37.0

L01BC06

ATC

capecitabine; oral

+∞

35.5

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

35.5

C71.4

ICD-10 Finland

Malignant neoplasm: Occipital lobe

+∞

34.5

C71.69

ICD-10 Finland

Malignant tumor of the cerebellum other or unspecified histology

+∞

33.4

C71.0

ICD-10 Finland

Malignant neoplasm: Cerebrum, except lobes and ventricles

+∞

33.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

33.4

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

9.1

33.4

Z2446

NOMESCO Finland

Social worker

2.8

33.1

172

641

B01AB05

ATC

enoxaparin; parenteral

1.9

32.8

546

3297

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.0

32.4

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

32.4

C71.70

ICD-10 Finland

Malignant tumor of the brainstem without histology

+∞

32.4

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

32.4

R4130

NOMESCO Finland

Speech therapy

4.3

32.2

205

G40

ICD-10 Finland

Epilepsy

7.1

31.9

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

31.7

1379

10963

C71.09

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology

+∞

31.3

ZX112

NOMESCO Finland

Subcutaneous

8.5

30.9

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

317.5

30.9

N03AX23

ATC

brivaracetam; systemic

38.7

30.3

C71.6

ICD-10 Finland

Malignant neoplasm: Cerebellum

+∞

30.3

C50.99

ICD-10 Finland

Breast, unspecified

+∞

30.3

C71

ICD-10 Finland

Malignant neoplasm of brain

+∞

30.3

HAC20

NOMESCO Finland

Total mastectomy

83.9

29.8

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.1

29.8

129

434

C71.03

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade IV glioma

+∞

29.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

29.1

857

6075

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

9.6

28.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.0

28.6

131

455

XA400

NOMESCO Finland

EEG

9.8

28.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

28.5

207

908

C71.91

ICD-10 Finland

Malignant tumor in unspecified location in the brain grade II glioma

+∞

28.2

C71.50

ICD-10 Finland

Malignant tumor of cerebral ventricle without histology

+∞

28.2

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

28.2

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

28.2

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

28.2

L02BA01

ATC

tamoxifen; oral

39.6

28.1

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

285.2

27.8

JN6AD

NOMESCO Finland

CT of torso and neck

10.9

27.8

N05BA04

ATC

oxazepam; oral

1.8

27.7

527

3293

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.7

27.4

140

ZX120

NOMESCO Finland

Intravenous

2.6

27.4

166

669

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

+∞

27.1

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

274.5

26.8

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

141.9

26.7

2151

FHL

Resection, big brain

141.9

26.7

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

26.4

348

1929

C71.81

ICD-10 Finland

Overall malignant tumor of the brain grade II glioma

+∞

26.1

9401/3-C71.1

ICD-O-3

Astrocytoma, anaplastic, NOS, of frontal lobe

+∞

26.1

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

33.5

25.6

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

25.0

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

25.0

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

58.8

25.0

XCK00

NOMESCO Finland

Perimetry

2.6

24.3

149

603

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

5.7

24.0

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

24.0

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

24.0

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

38.0

24.0

WX730

NOMESCO Finland

Conventional respirator

5.3

23.9

WX892

NOMESCO Finland

Monitored bed care

2.4

23.9

171

745

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

68.3

23.8

Z3231

NOMESCO Finland

Registered nurse

1.7

23.8

513

3303

G91.0

ICD-10 Finland

Communicating hydrocephalus

7.9

23.4

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

9.8

23.2

N03AX22

ATC

perampanel; oral

28.6

23.2

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

23.0

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

23.0

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

+∞

23.0

C71.59

ICD-10 Finland

Malignant tumor of cerebral ventricle other or unspecified histology

+∞

23.0

HA1AA

NOMESCO Finland

X-ray mammography

3.8

22.9

188

XW000

NOMESCO Finland

Bone marrow biopsy

3.6

22.8

212

XX1AD

NOMESCO Finland

Other CT-examination

84.4

22.7

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

232.5

22.7

L02BG04

ATC

letrozole; oral

4.7

22.5

113

9440/3-C71.0

ICD-O-3

Glioblastoma, NOS, of cerebrum

+∞

21.9

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

21.9

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

+∞

21.9

H02AB04

ATC

methylprednisolone; systemic

1.9

21.9

291

1612

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

8.8

21.6

N88

ICPC

Epilepsy

7.3

21.2

ZXA00

NOMESCO Finland

Right side

1.7

21.2

496

3251

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.1

21.2

289

D69.5

ICD-10 Finland

Secondary thrombocytopenia

34.2

21.1

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.9

21.0

167

ZXD05

NOMESCO Finland

Urgent procedure

1.6

21.0

580

3969

WX725

NOMESCO Finland

Noninvasive ventilation

2.7

21.0

117

452

R51.80

ICD-10 Finland

Headache

1.9

20.9

313

1801

9440/3-C71.8

ICD-O-3

Glioblastoma, NOS, of overlapping lesion of brain

+∞

20.9

C71.7

ICD-10 Finland

Malignant neoplasm: Brain stem

+∞

20.9

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

20.9

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.5

20.9

116

A04AD12

ATC

aprepitant; systemic

212.0

20.6

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

111.2

20.6

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

42.1

20.5

AAF00

NOMESCO Finland

Ventriculostomy

6.8

20.4

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

6.1

20.3

A06AD11

ATC

lactulose; oral

1.9

20.2

288

1631

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

6.4

20.1

R93.0

ICD-10 Finland

Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

23.6

20.0

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

3.6

19.9

188

C71.49

ICD-10 Finland

Malignant tumor in occipital lobe other or unspecified histology

+∞

19.8

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

+∞

19.8

G93.6

ICD-10 Finland

Cerebral oedema

+∞

19.8

C71.02

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles grade III glioma

+∞

19.8

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

19.8

C71.65

ICD-10 Finland

Malignant tumor of the cerebellum primary neuroectodermal tumor

+∞

19.8

22500

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

+∞

19.8

D33.10

ICD-10 Finland

Benign pilosytic astrocytoma of brain stem

+∞

19.8

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

19.8

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

19.8

RS221, ,

NOMESCO Finland

4.7

19.7

9161/1-C71.6

ICD-O-3

Hemangioblastoma of cerebellum, NOS

201.9

19.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

19.3

210

1082

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

19.2

199

1007

N18

ICPC

Paralysis/weakness

3.6

19.0

184

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

18.9

115

464

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

5.8

18.9

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

4.1

18.8

130

9401/3-C71.2

ICD-O-3

Astrocytoma, anaplastic, NOS, of temporal lobe

+∞

18.8

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

18.8

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

18.8

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

18.8

N75

ICPC

Benign neoplasm nervous system

101.0

18.6

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.5

18.6

23810

ICD-8 Finland

Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain

191.7

18.6

N28

ICPC

Limited function/disability (N)

3.9

18.4

141

2152

FHL

Extraction, big brain

30.3

18.3

Z3226

NOMESCO Finland

Physiotherapist

1.7

18.1

342

2104

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

33.2

18.0

AA1AA

NOMESCO Finland

Head X-ray examination

6.7

17.9

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

4.2

17.7

114

1911X

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUST]

+∞

17.7

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

17.7

L02BB03

ATC

bicalutamide; oral

+∞

17.7

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

17.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.9

17.7

309

R50.9

ICD-10 Finland

Fever, unspecified

1.8

17.6

275

1599

N03AX11

ATC

topiramate; oral

3.5

17.6

179

D33.14

ICD-10 Finland

Hemangioblastoma and cerebellum

181.5

17.5

2159

FHL

Other measure in this category

181.5

17.5

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

181.5

17.5

ZXY02

NOMESCO Finland

Neuropsychologist

6.9

17.0

G41.2

ICD-10 Finland

Complex partial status epilepticus

25.8

16.9

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

25.8

16.9

WW200, ,

SPAT

0.5

16.9

163

3057

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

14.2

16.8

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

63.9

16.7

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

16.7

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

16.7

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

16.7

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

16.7

C71.74

ICD-10 Finland

Malignant tumor of the brainstem ependyoma

+∞

16.7

L01CB01

ATC

etoposide; systemic

+∞

16.7

D33.12

ICD-10 Finland

Cerebellum

+∞

16.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

16.7

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

15.2

16.7

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

171.3

16.5

WF099

NOMESCO Finland

Other radiotherapy

27.8

16.5

R41.0

ICD-10 Finland

Disorientation, unspecified

2.8

16.4

299

102

Kela drug reimbursment

Diabetes insipidus

23.2

16.4

PA2AD

NOMESCO Finland

CT angiography of brain

6.2

16.4

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.8

16.4

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.7

16.3

346

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

16.2

214

3640

R4190

NOMESCO Finland

Nutritional therapy

3.0

16.0

243

H53.2

ICD-10 Finland

Diplopia

2.8

15.9

299

N19

ICPC

Speech disorder

4.0

15.9

115

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

14.6

15.8

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

15.6

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

15.6

9421/1-C71.9

ICD-O-3

Pilocytic astrocytoma of brain, NOS

+∞

15.6

C71.51

ICD-10 Finland

Malignant tumor of cerebral ventricle ependymoma

+∞

15.6

19109

ICD-8 Finland

Malignant neoplasm of brain, Unspecified

+∞

15.6

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

15.6

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

15.6

WW409

NOMESCO Finland

Other aferesis

85.7

15.6

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

161.2

15.5

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.7

15.4

131

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

15.3

166

3006

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.1

15.2

101

H47.2

ICD-10 Finland

Optic atrophy

13.1

15.2

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

15.1

153

767

E23.2

ICD-10 Finland

Diabetes insipidus

23.6

15.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

15.0

231

1334

WPB10

NOMESCO Finland

Making a convalescent care decision

31.9

14.8

ZXA05

NOMESCO Finland

Left side

1.6

14.8

428

2928

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.5

14.7

179

3133

C71.61

ICD-10 Finland

Malignant tumor of cerebellum grade II glioma

+∞

14.6

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

14.6

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

14.6

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

14.6

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

14.6

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

14.6

2396A

ICD-9 Finland

Neoplasm of unspecified nature, Brain

+∞

14.6

D33.03

ICD-10 Finland

Pilosytic lateral astrocytoma of the strobe brain

+∞

14.6

9440/3-C71.4

ICD-O-3

Glioblastoma, NOS, of occipital lobe

+∞

14.6

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

14.6

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

14.6

N03AF04

ATC

eslicarbazepine; oral

80.7

14.6

L28

ICPC

Limited function/disability (L)

1.7

14.5

330

2126

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

151.0

14.5

N03AX09

ATC

lamotrigine; oral

2.4

14.4

423

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

14.4

514

6903

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.6

14.3

212

3508

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

17.1

14.3

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

14.2

332

2153

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

19.3

14.2

H01AC01

ATC

somatropin; parenteral

10.5

14.2

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

14.2

317

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

42.8

14.1

KAC10

NOMESCO Finland

Total nephrectomy with capsule

42.8

14.1

C10AX09

ATC

ezetimibe; oral

0.4

14.1

1968

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

14.0

160

839

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

13.9

112

513

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.0

13.9

202

CS494

NOMESCO Finland

Other visual field testing

3.0

13.9

202

TPX15

NOMESCO Finland

Removal of vascular injection port

30.2

13.9

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

53.7

13.8

NK6AN

NOMESCO Finland

Total body bone isotope imaging

23.9

13.8

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.5

13.7

119

2327

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

13.7

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.6

13.7

305

C10AA07

ATC

rosuvastatin; oral

0.6

13.6

282

4284

L03

ICPC

Low back symptom/complaint

0.6

13.6

221

3572

D43.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system

+∞

13.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

13.6

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

13.6

C71.42

ICD-10 Finland

Malignant tumor of the occipital lobe grade III glioma

+∞

13.6

C71.92

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade III glioma

+∞

13.6

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

13.6

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

13.6

C72.9

ICD-10 Finland

Malignant neoplasm: Central nervous system, unspecified

+∞

13.6

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

13.6

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

13.6

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

140.9

13.5

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

140.9

13.5

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

13.9

13.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

13.2

127

625

R03AC02

ATC

salbutamol; inhalant

0.7

13.2

656

8312

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

13.1

127

626

N05BA01

ATC

diazepam; systemic, rectal

1.7

13.0

244

1491

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.4

13.0

142

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

19.2

12.9

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

12.8

114

545

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

70.3

12.6

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

12.6

443

WZC15, ,

NOMESCO Finland

32.2

12.6

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

12.5

973

11469

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

12.5

AA5JS

NOMESCO Finland

Extensive PET-MRI of brain metabolism

+∞

12.5

19107

ICD-8 Finland

Malignant neoplasm of brain, Cerebelli

+∞

12.5

9421/1-C71.6

ICD-O-3

Pilocytic astrocytoma of cerebellum, NOS

+∞

12.5

1CD02, ,

NOMESCO Finland

+∞

12.5

19100

ICD-8 Finland

Malignant neoplasm of brain, Lobi frontalis

+∞

12.5

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

12.5

C71.79

ICD-10 Finland

Malignant tumor of the brainstem other or unspecified histology

+∞

12.5

9450/3-C71.3

ICD-O-3

Oligodendroglioma, NOS, of parietal lobe

+∞

12.5

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

+∞

12.5

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

12.5

9382/3-C71.9

ICD-O-3

Oligoastrocytoma, NOS, of brain, NOS

+∞

12.5

9470/3-C71.6

ICD-O-3

Medulloblastoma, NOS, of cerebellum, NOS

+∞

12.5

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

12.5

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

24.5

12.5

OAB43, ,

SPAT

0.6

12.4

220

3486

ZXD35

NOMESCO Finland

Usual procedure

2.6

12.4

279

N02AA01

ATC

morphine; systemic, rectal

4.7

12.4

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

11.7

12.3

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

11.7

12.3

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

10.6

12.2

SPAT1153

SPAT

Removal of sutures

1.5

12.2

514

3791

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

12.2

443

A07AA02

ATC

nystatin; oral

2.2

12.1

103

483

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

12.0

356

KCD02

NOMESCO Finland

Transurethral resection of bladder

10.1

12.0

M01AH05

ATC

etoricoxib; oral

0.7

12.0

771

9406

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

9.7

11.7

F80.1

ICD-10 Finland

Expressive language disorder

4.4

11.7

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.6

11.7

206

3272

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

30.2

11.6

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.6

11.6

210

3316

AAA00

NOMESCO Finland

Exploratory craniotomy

65.3

11.6

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.1

11.6

158

R1260

NOMESCO Finland

Evaluation of communicative skills

3.0

11.5

164

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

11.5

9450/3-C71.2

ICD-O-3

Oligodendroglioma, NOS, of temporal lobe

+∞

11.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

11.5

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

11.5

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

11.5

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

11.5

D43

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of brain and central nervous system

+∞

11.5

128

Kela drug reimbursment

Cancers of female genital organs

+∞

11.5

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

11.5

N05AD01

ATC

haloperidol; systemic

2.6

11.5

272

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

120.7

11.4

D33.15

ICD-10 Finland

Another benign tumor of the cerebellum

120.7

11.4

OAA41

NOMESCO Finland

Health check based on individual needs

120.7

11.4

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

120.7

11.4

M25.5

ICD-10 Finland

Pain in joint

0.6

11.4

289

4212

R11

ICD-10 Finland

Nausea and vomiting

1.9

11.3

152

842

ZXH01

NOMESCO Finland

Procedure performed within operation theatre

20.1

11.1

AAK00

NOMESCO Finland

Cranioplasty

20.1

11.1

WX002

NOMESCO Finland

Sedation and analgesia

1.6

11.0

323

2205

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

43.5

10.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

10.9

282

1869

AAF15

NOMESCO Finland

Ventriculoatrial shunt

15.6

10.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

10.8

292

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

10.8

113

575

A06AH03

ATC

naloxegol; oral

8.9

10.8

G41.0

ICD-10 Finland

Grand mal status epilepticus

17.9

10.7

XX9XW, ,

NOMESCO Finland

5.6

10.7

GD1AA, ,

SPAT

0.4

10.7

1303

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

13.0

10.6

SPAT1290

SPAT

Preparation of deceased person

60.3

10.6

N03AX15

ATC

zonisamide; oral

11.3

10.5

S18

ICPC

Laceration/cut

1.4

10.5

752

6062

C01DA14

ATC

isosorbide mononitrate; oral

0.5

10.5

121

2169

N29

ICPC

Neurological sympt/complt other

3.0

10.4

152

L02BG06

ATC

exemestane; oral

110.6

10.4

Y77

ICPC

Malignant neoplasm prostate

110.6

10.4

X76

ICPC

Malignant neoplasm breast female

110.6

10.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

10.4

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

10.4

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

10.4

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

10.4

C72.3

ICD-10 Finland

Malignant neoplasm: Optic nerve

+∞

10.4

1916A

ICD-9 Finland

Malignant neoplasm of brain, Cerebellum[PIKKUAIVOJEN SYÖPÄ, ASTROCYTOMA (GR I-II)]

+∞

10.4

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

+∞

10.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

10.4

ZX131

NOMESCO Finland

Intrathecal

+∞

10.4

C72.00

ICD-10 Finland

Malignant tumor of the spinal cord without histology

+∞

10.4

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

10.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

10.4

AA003

NOMESCO Finland

Adjuvant radiotherapy of brain

+∞

10.4

C71.63

ICD-10 Finland

Malignant tumor of cerebellum grade IV glioma

+∞

10.4

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

10.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

10.4

R83

ICPC

Respiratory infection other

0.6

10.4

213

3267

9539/1-C70.0

ICD-O-3

Atypical meningioma of cerebral meninges

32.7

10.3

AAF50

NOMESCO Finland

Third ventriculostomy

32.7

10.3

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

23.5

10.2

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.0

10.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

10.1

165

969

N02BE01

ATC

paracetamol; systemic, rectal

1.4

10.0

1645

15078

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

9.9

102

515

H47.1

ICD-10 Finland

Papilloedema, unspecified

7.7

9.9

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

12.2

9.8

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

26.1

9.8

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

20.1

9.8

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.9

9.7

L02BG03

ATC

anastrozole; oral

55.3

9.6

ZXC96

NOMESCO Finland

Robot assisted procedure

5.3

9.6

C10AA05

ATC

atorvastatin; oral

0.7

9.6

465

6017

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.4

9.6

284

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.5

9.5

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

100.5

9.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

100.5

9.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

100.5

9.4

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

100.5

9.4

SPAT1229

SPAT

Assessment of need for aid

1.8

9.4

132

741

D32.05

ICD-10 Finland

Cerebral meninges

17.6

9.4

9391/3-C71.7

ICD-O-3

Ependymoma, NOS, of brain stem

+∞

9.4

197

Kela drug reimbursment

Sunitinib

+∞

9.4

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

9.4

9591/3-C71.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS

+∞

9.4

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

9.4

C71.71

ICD-10 Finland

Malignant tumor of the brainstem grade II glioma

+∞

9.4

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

9.4

WW402

NOMESCO Finland

Leucoferesis

+∞

9.4

19101

ICD-8 Finland

Malignant neoplasm of brain, Lobi temporalis

+∞

9.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

9.4

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

9.4

C70.9

ICD-10 Finland

Malignant neoplasm: Meninges, unspecified

+∞

9.4

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

9.4

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

9.4

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

9.4

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

9.4

9400/3-C71.0

ICD-O-3

Astrocytoma, NOS, of cerebrum

+∞

9.4

C72.09

ICD-10 Finland

Malignant tumor of the spinal cord other histology

+∞

9.4

SPAT1109

SPAT

Analgesia with portable analgesic pump

12.4

9.4

ZX108

NOMESCO Finland

Inhalation

6.9

9.3

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

9.1

269

3825

2250A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

36.9

9.0

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

2.9

9.0

138

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

18.7

8.9

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

12.6

8.9

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

8.8

320

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

10.7

8.8

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

8.7

401

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.7

8.7

C90.0

ICD-10 Finland

Multiple myeloma

50.2

8.7

C07AB07

ATC

bisoprolol; oral

0.7

8.6

588

7241

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

7.7

8.6

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.6

8.6

168

2619

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

8.6

462

3533

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

8.6

126

718

R03DC03

ATC

montelukast; oral

0.6

8.6

113

1950

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

8.6

703

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

16.3

8.5

N80

ICPC

Head injury other

2.7

8.5

176

A86

ICD-10 Finland

Unspecified viral encephalitis

7.0

8.5

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

27.6

8.5

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.8

8.4

143

C50

ICD-10 Finland

Malignant neoplasm of breast

90.4

8.4

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

90.4

8.4

1CX01, ,

NOMESCO Finland

90.4

8.4

AA5NK

NOMESCO Finland

Tractography within white matter of central nervous system

90.4

8.4

M79.6

ICD-10 Finland

Pain in limb

0.7

8.4

455

5809

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.6

8.4

190

2860

Z50.5

ICD-10 Finland

Speech therapy

3.2

8.4

101

R01AD12

ATC

fluticasone furoate; nasal

0.7

8.4

295

4057

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

8.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

8.3

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

8.3

C70.0

ICD-10 Finland

Malignant neoplasm: Cerebral meninges

+∞

8.3

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

8.3

AAF30

NOMESCO Finland

Implantation of intraventricular injection device

+∞

8.3

9445/3-C71.9

ICD-O-3

Glioblastoma, IDH-mutant of brain, NOS

+∞

8.3

8000/3-C71.2

ICD-O-3

Neoplasm, malignant of temporal lobe

+∞

8.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

8.3

C71.5

ICD-10 Finland

Malignant neoplasm: Cerebral ventricle

+∞

8.3

C71.73

ICD-10 Finland

Malignant tumor of the brain stem grade IV glioma

+∞

8.3

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

8.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

8.3

8000/3-C71.1

ICD-O-3

Neoplasm, malignant of frontal lobe

+∞

8.3

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

8.3

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

8.3

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

8.3

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

8.3

1919X

ICD-9 Finland

Malignant neoplasm of brain, Brain, unspecified[TARKEMMIN MÄÄRITTELEMÄTÖN AIVOSYÖPÄ,EI HIST VAHV]

+∞

8.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

8.3

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

8.3

C71.41

ICD-10 Finland

Malignant tumor of occipital lobe grade II glioma

+∞

8.3

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

8.3

3AA13, ,

NOMESCO Finland

+∞

8.3

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

8.3

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

9.5

8.3

A10BK03

ATC

empagliflozin; oral

0.4

8.2

1091

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

8.2

324

L13

ICPC

Hip symptom/complaint

0.6

8.2

130

2133

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

8.2

175

2670

M54.4

ICD-10 Finland

Lumbago with sciatica

0.6

8.1

132

2153

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

33.5

8.1

A10AB05

ATC

insulin aspart; parenteral

1.7

8.1

142

853

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.6

8.0

180

2714

ZX121

NOMESCO Finland

Central venous catheter

13.1

7.9

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.6

7.9

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

7.8

108

604

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.5

7.8

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

8.5

7.8

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

7.8

482

1XC02, ,

NOMESCO Finland

7.0

7.8

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.5

7.8

1600

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.5

7.7

1275

R42

ICD-10 Finland

Dizziness and giddiness

1.4

7.6

377

2838

Z31.5

ICD-10 Finland

Genetic counselling

2.1

7.5

322

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

7.5

793

9247

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

4.3

7.5

NG1AA, ,

SPAT

0.3

7.5

666

SFA20

NOMESCO Finland

Two-surface restoration

0.8

7.4

757

8875

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

2.7

7.4

142

D33.1

ICD-10 Finland

Benign neoplasm: Brain, infratentorial

80.4

7.4

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

80.4

7.4

C20

ICD-10 Finland

Malignant neoplasm of rectum

80.4

7.4

D33.04

ICD-10 Finland

Temporal lobe

80.4

7.4

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

80.4

7.4

AA5GG

NOMESCO Finland

Extensive functional MRI examination of brain withhigh intensity magnet

80.4

7.4

DFF20

NOMESCO Finland

Audiometry for children

13.4

7.4

N06DX01

ATC

memantine; oral

0.4

7.4

878

OAA67, ,

SPAT

0.6

7.3

1597

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

7.3

9400/3-C71.3

ICD-O-3

Astrocytoma, NOS, of parietal lobe

+∞

7.3

1912X

ICD-9 Finland

Malignant neoplasm of brain, Temporal lobe[AIVOJEN OHIMOLOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUS]

+∞

7.3

1BC01, ,

NOMESCO Finland

+∞

7.3

9382/3-C71.2

ICD-O-3

Oligoastrocytoma, NOS, of temporal lobe

+∞

7.3

9380/3-C71.1

ICD-O-3

Glioma, malignant of frontal lobe

+∞

7.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

7.3

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

7.3

1990X

ICD-9 Finland

Malignant neoplasm without specification of site, Disseminated

+∞

7.3

C71.62

ICD-10 Finland

Malignant tumor of cerebellum grade III glioma

+∞

7.3

Q85.1

ICD-10 Finland

Tuberous sclerosis

+∞

7.3

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

7.3

1911A

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,ASTROCYTOMA (GR I-II)]

+∞

7.3

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

7.3

9380/3-C71.2

ICD-O-3

Glioma, malignant of temporal lobe

+∞

7.3

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

7.3

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

7.3

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

7.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

7.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

7.3

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

7.3

C71.04

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles ependyoma

+∞

7.3

9450/3-C71.0

ICD-O-3

Oligodendroglioma, NOS, of cerebrum

+∞

7.3

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

7.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

7.3

AA5AK

NOMESCO Finland

Brain spectroscopy

+∞

7.3

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.5

7.3

173

R74

ICPC

Upper respiratory infection acute

0.7

7.2

306

4086

L15

ICPC

Knee symptom/complaint

0.7

7.2

210

3005

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

30.1

7.1

Q85.0

ICD-10 Finland

Neurofibromatosis (nonmalignant)

30.1

7.1

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.5

7.1

1152

XX2XW

NOMESCO Finland

Other teleradiological consultation

7.9

7.1

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

10.1

7.0

207

Kela drug reimbursment

Chronic arrhythmias

0.6

7.0

114

1859

ZZR00

NOMESCO Finland

Flap of skin

5.8

6.9

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

13.8

6.9

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

6.8

131

OAB42, ,

SPAT

0.5

6.8

1185

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.8

6.8

XX4AW, ,

NOMESCO Finland

9.3

6.8

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

5.7

6.8

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

6.7

117

1880

301

Kela drug reimbursment

Growth hormone

16.7

6.7

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

16.7

6.7

2132

FHL

Ventricular operators sunt

22.6

6.7

S77

ICPC

Malignant neoplasm of skin

22.6

6.7

D33.7

ICD-10 Finland

Benign neoplasm: Other specified parts of central nervous system

22.6

6.7

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

22.6

6.7

B01AB04

ATC

dalteparin; parenteral

2.0

6.6

373

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.0

6.6

M54.5

ICD-10 Finland

Low back pain

0.7

6.6

386

4906

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

3.6

6.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

6.6

185

1248

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.3

6.6

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

12.3

6.6

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

12.3

6.6

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.4

6.6

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.4

6.5

170

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.4

6.5

183

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

5.3

6.5

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

6.4

153

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.7

6.4

316

4127

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

70.1

6.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

70.1

6.4

ZX000

NOMESCO Finland

Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy

70.1

6.4

R10.1

ICD-10 Finland

Pain localized to upper abdomen

0.6

6.4

135

2071

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

6.4

102

598

J05AB11

ATC

valaciclovir; oral

1.5

6.3

209

1458

OAA80, ,

SPAT

0.5

6.3

959

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

5.2

6.3

OAB48, ,

SPAT

0.6

6.3

1521

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.5

6.3

R05

ICPC

Cough

0.7

6.3

221

3056

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

18.1

6.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

6.3

110

662

C72.01

ICD-10 Finland

Malignant tumor of the spinal cord grade II glioma

+∞

6.3

AAM10

NOMESCO Finland

Excision of intracerebral abscess

+∞

6.3

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

6.3

9382/3-C71.3

ICD-O-3

Oligoastrocytoma, NOS, of parietal lobe

+∞

6.3

AA049

NOMESCO Finland

Radiotherapy of metasthasis in the brain

+∞

6.3

9401/3-C71.3

ICD-O-3

Astrocytoma, anaplastic, NOS, of parietal lobe

+∞

6.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

6.3

2141

FHL

Stereotactic biopsy of the brain

+∞

6.3

9391/3-C71.5

ICD-O-3

Ependymoma, NOS, of ventricle, NOS

+∞

6.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

6.3

9391/3-C72.0

ICD-O-3

Ependymoma, NOS, of spinal cord

+∞

6.3

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

6.3

L01CA04

ATC

vinorelbine; systemic

+∞

6.3

C71.66

ICD-10 Finland

Malignant tumor of the cerebellum medullobastoma

+∞

6.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

6.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

6.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

6.3

19105

ICD-8 Finland

Malignant neoplasm of brain, Hypothalami

+∞

6.3

D42.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Meninges, unspecified

+∞

6.3

L01XE04

ATC

[U] sunitinib

+∞

6.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

6.3

YX9AW, ,

NOMESCO Finland

+∞

6.3

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

6.3

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

6.3

1911F

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,MUU]

+∞

6.3

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

6.3

C75.3

ICD-10 Finland

Malignant neoplasm: Pineal gland

+∞

6.3

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

6.3

C71.05

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles primary neuroectodermal tumor

+∞

6.3

9424/3-C71.9

ICD-O-3

Pleomorphic xanthoastrocytoma, NOS, of brain, NOS

+∞

6.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

6.3

1AC01, ,

NOMESCO Finland

+∞

6.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

6.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

6.3

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

6.2

264

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

26.8

6.2

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

26.8

6.2

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

7.0

6.2

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.6

6.2

121

1891

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.1

6.2

258

ZX100

NOMESCO Finland

Oral

3.1

6.2

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

7.7

6.1

I48

ICD-10 Finland

Atrial fibrillation and flutter

0.7

6.1

210

2916

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

3.0

6.1

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

6.1

164

G03.9

ICD-10 Finland

Meningitis, unspecified

8.6

6.1

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.8

6.0

702

8169

SFA10

NOMESCO Finland

One-surface restoration

0.8

6.0

707

8218

NB1AA, ,

SPAT

0.2

6.0

311

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726) Immunohistochemistry procedure

820

400

33.27

307.65

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

387

49.86

307.65

1.7

1.9

—

(3003396) Base excess in Arterial blood by calculation

699

1611

6.04

303.71

7.3

7.6

1.13

1.19

mmol/l

0.19

534

1269

(3027801) Oxygen [Partial pressure] in Arterial blood

698

1615

6.01

301.79

7.3

7.6

17.54

11.67

kpa

77.41

668

1541

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

698

1615

6.01

301.79

7.3

7.6

4.95

5.08

kpa

3.32

668

1542

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

262

+∞

279.68

1.0

0.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

136

103.90

263.50

1.1

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

764

2214

4.88

248.07

2.1

2.3

27.36

29.95

23.95

744

2142

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

104

68.38

190.27

1.4

1.1

—

(40768804) Tissue Pathology biopsy report

1066

4828

3.49

170.24

3.0

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

964

4139

3.49

167.13

2.7

2.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

158

+∞

166.97

1.1

0.0

—

(3044290) Cell count panel - Cerebral spinal fluid

236

322

8.14

166.33

2.0

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

169

150

12.18

164.10

2.1

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

245

360

7.58

161.74

2.0

1.4

2541.96

1494.59

e6/l

0.48

198

304

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

244

360

7.55

160.46

2.0

1.4

54.82

35.04

e6/l

0.33

191

294

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1326

7117

3.40

155.41

13.1

3.9

9.89

12.25

umol/l

16.37

1296

6663

(3033658) Prothrombin time (PT) actual/Normal

856

3593

3.36

150.81

4.1

3.7

94.60

88.40

12.56

834

3489

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

128

16.57

149.93

2.4

2.3

54.19

50.90

umol/l

0.35

112

(3016018) Differential panel - Cerebral spinal fluid

162

156

11.18

148.83

1.8

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1217

6423

3.17

142.44

8.7

5.6

1.20

1.21

mmol/l

13.43

1180

5766

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

779

3192

3.31

141.17

2.5

2.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

224

365

6.76

133.76

1.8

1.2

3.61

3.84

mmol/l

1.57

218

343

(3002173) Hemoglobin [Mass/volume] in Arterial blood

444

1317

4.02

131.36

8.9

8.4

127.36

123.74

g/l

3.23

430

1283

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1273

7103

3.05

131.01

9.1

5.9

1.20

1.21

mmol/l

8.87

1136

6059

(3016502) Oxygen saturation in Arterial blood

455

1439

3.77

122.06

9.3

8.0

97.85

95.22

19.93

438

1388

(3013826) Glucose [Moles/volume] in Serum or Plasma

1438

8943

2.99

114.78

8.6

4.4

6.74

mmol/l

0.04

1406

8302

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

958

4848

2.82

113.57

2.7

2.1

173.09

242.45

u/l

1.45

940

4553

(3013650) Neutrophils [#/volume] in Blood by Automated count

1354

8389

2.77

104.50

18.7

6.7

4.18

4.24

e9/l

0.48

1192

7258

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

100

12.46

100.06

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1122

6470

2.60

97.97

3.1

2.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

527

2117

3.00

93.45

4.6

3.0

0.84

0.83

mmol/l

1.45

507

1961

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

105

112

9.82

89.25

1.9

1.3

2.52

2.01

mmol/l

2.34

107

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

13.19

88.34

2.1

—

(3022096) Basophils/100 leukocytes in Blood

1139

6856

2.47

87.19

10.3

5.8

0.51

0.68

20.96

1109

6359

(40760892) CBC W Ordered Manual Differential panel - Blood

1155

7032

2.45

85.68

11.1

6.0

—

(3011412) CD3 cells [#/volume] in Blood

103

9.94

84.17

2.1

2.3

1.01

1.32

e9/l

1.98

(3015377) Calcium [Moles/volume] in Serum or Plasma

843

4525

2.45

81.85

8.2

2.0

2.36

2.35

mmol/l

0.38

787

3855

(3019069) Monocytes/100 leukocytes in Blood

1153

7109

2.40

81.76

10.6

6.0

8.79

8.60

1.16

1124

6620

(3006504) Eosinophils/100 leukocytes in Blood

1149

7076

2.40

81.66

10.4

5.8

1.97

2.94

44.96

1117

6574

(3023410) Appearance of Cerebral spinal fluid

119

166

7.54

81.42

2.0

1.5

—

(3001604) Monocytes [#/volume] in Blood

1197

7591

2.37

78.30

10.4

5.6

0.57

0.59

e9/l

1.59

1028

6564

(3000991) Gas panel - Venous blood

347

1211

3.24

77.34

7.4

8.5

—

(3006315) Basophils [#/volume] in Blood

1196

7610

2.35

77.22

10.4

5.6

0.03

0.04

e9/l

25.05

1028

6578

(3002030) Lymphocytes/100 leukocytes in Blood

1161

7310

2.34

76.61

10.7

5.8

23.75

28.27

35.12

1132

6837

(3019198) Lymphocytes [#/volume] in Blood

1208

7813

2.31

73.71

10.6

5.7

1.54

1.90

e9/l

19.51

1044

6898

(3036481) Cortisol [Moles/volume] in Serum or Plasma

366

1358

3.06

73.22

2.7

1.8

333.14

358.99

nmol/l

0.63

347

1238

(3018010) Neutrophils/100 leukocytes in Blood

1142

7233

2.29

73.03

10.4

5.7

61.34

57.03

24.22

1113

6752

(3013115) Eosinophils [#/volume] in Blood

1211

7884

2.29

72.12

11.1

5.8

0.13

0.20

e9/l

54.14

1043

6911

(3024561) Albumin [Mass/volume] in Serum or Plasma

996

5987

2.28

71.93

6.0

4.1

34.79

36.03

g/l

8.91

951

5508

(3018418) pH of Serum or Plasma

757

4055

2.37

71.81

4.7

3.2

7.40

0.17

144

701

(3023368) Bacteria identified in Blood by Culture

717

3772

2.38

70.68

5.0

3.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

11.65

67.54

3.1

2.7

28.53

29.67

umol/l

0.27

(3022217) INR in Platelet poor plasma by Coagulation assay

1068

6759

2.20

66.12

8.7

16.2

1.13

1.31

inr

12.96

323

1966

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

235

730

3.50

62.57

11.9

11.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

320

1240

2.87

58.39

6.4

7.2

1.40

1.44

mmol/l

0.24

308

1208

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

23.80

58.36

1.9

1.8

—

(40758558) Short blood count panel - Blood

658

3630

2.19

55.38

14.5

4.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

8.69

54.72

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1324

16292

0.48

51.66

4.0

4.8

2.83

2.75

mmol/l

2.80

1204

15123

(3020779) Urea [Moles/volume] in Serum or Plasma

312

1271

2.71

51.38

4.9

7.4

6.69

9.80

mmol/l

14.49

295

1206

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

8.99

50.67

2.2

1.2

63.00

53.30

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1293

16001

0.49

50.19

3.7

4.4

4.69

4.62

mmol/l

1.81

1179

14935

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1287

15887

0.50

47.79

3.6

4.3

1.42

1.43

mmol/l

0.15

1180

14745

(3003694) ABO and Rh group [Type] in Blood

682

4037

2.03

46.02

1.3

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

13.70

46.01

1.8

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.59

45.51

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

115

270

4.45

45.13

3.2

5.3

352.51

362.76

umol/l

0.30

106

235

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1480

11458

2.02

44.47

14.7

5.4

74.36

76.11

u/l

0.84

1448

10651

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

11.45

44.09

1.9

1.1

18.60

23.00

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

239

922

2.80

43.40

13.4

7.1

25.29

24.55

mmol/l

2.42

222

880

(3019060) Gas panel - Arterial blood

245

961

2.76

43.08

10.7

5.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

466

2463

2.15

42.09

4.1

2.1

2.44

mmol/l

0.44

429

2081

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

7.23

41.63

2.0

2.4

465.06

490.97

e6/l

0.13

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

444

2326

2.16

40.90

2.1

1.7

—

(3021589) Normoblasts [#/volume] in Blood

982

6777

1.85

40.38

17.4

8.1

0.00

e9/l

0.83

780

5522

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1250

15347

0.53

40.09

3.4

3.9

1.29

1.31

mmol/l

0.46

1149

14134

(3017181) Myelocytes/100 leukocytes in Blood

263

1112

2.56

39.67

4.3

3.9

1.75

0.72

8.98

168

298

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

7.03

38.67

2.1

2.3

0.15

0.21

e9/l

1.63

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

341

1645

2.28

38.30

2.0

1.7

—

(3039000) Anion gap in Blood

116

313

3.87

37.74

16.7

7.5

10.56

11.54

mmol/l

2.57

101

282

(3018572) Chloride [Moles/volume] in Blood

116

314

3.85

37.57

16.7

7.5

105.65

105.21

mmol/l

0.31

101

283

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

340

1653

2.26

37.42

2.0

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

158

533

3.13

36.36

1.9

2.3

270.71

455.12

ug/l

0.77

149

497

(3030467) Casts [#/volume] in Urine by Automated count

635

3937

1.88

35.64

3.1

2.9

0.48

0.38

e6/l

0.39

488

2967

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

175

636

2.91

35.31

2.8

1.5

36.08

2.68

ug/l

0.62

131

468

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1209

14810

0.56

34.81

4.8

5.6

39.20

39.99

mmol/mol

2.28

1118

13796

(36304419) Bacteria [Presence] in Urine

625

3884

1.87

34.65

3.1

2.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

165

4.81

33.78

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

672

4337

1.81

32.59

3.1

3.0

30.20

74.55

e6/l

1.85

516

3301

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

282

1340

2.28

32.52

4.7

3.0

252.90

233.55

u/l

1.87

272

1253

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

172

4.61

32.13

5.6

7.4

9.60

11.40

mg/l

2.94

159

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

251

3.88

31.03

4.2

5.8

251.81

477.31

iu/ml

0.55

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

5.87

29.82

1.1

1.35

1.08

u/l

1.18

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.73

29.36

1.4

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

124

411

3.15

29.34

3.4

4.3

0.40

0.35

u/ml

0.70

242

(3002179) Metamyelocytes/100 leukocytes in Blood

227

1032

2.35

28.89

3.9

3.7

1.27

0.57

3.09

135

264

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

7.00

28.89

1.1

956.87

115.99

ng/l

0.74

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

154

587

2.75

28.34

13.7

5.1

1.57

1.64

0.59

139

552

(3007930) Methemoglobin/Hemoglobin.total in Blood

152

579

2.75

28.01

13.8

5.2

1.02

0.88

4.86

137

545

(3021440) Promyelocytes/100 leukocytes in Blood

230

1069

2.30

27.77

4.4

3.9

0.23

0.04

4.19

136

253

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

197

859

2.43

27.50

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

117

5.07

27.31

1.1

1.2

94.15

37.36

mg/l

1.13

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1326

15549

0.59

26.99

4.1

4.4

5.89

5.96

mmol/l

0.98

1203

14205

(3047181) Lactate [Moles/volume] in Blood

130

467

2.90

26.71

15.6

6.3

1.70

1.28

mmol/l

1.96

113

415

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

8.63

26.67

5.3

2.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

112

5.11

26.63

1.1

591.17

262.83

mg/l

1.06

100

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

6.47

25.66

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

6.03

25.63

2.6

2.3

39.25

45.01

1.27

(3018095) Leukocytes [#/volume] in Urine

730

5162

1.64

23.71

3.7

3.4

37.53

95.08

e6/l

3.81

542

3558

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

113

4.79

23.42

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

118

4.67

23.17

3.1

2.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.15

23.11

1.7

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

375

2221

1.84

23.01

2.6

2.7

2.49

2.54

e6/l

0.04

195

1173

(3026008) Bacteria identified in Urine by Culture

621

4248

1.66

22.81

3.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

396

2391

1.81

22.80

2.6

1.08

1.24

e6/l

0.26

217

1345

(3008757) Leukocyte morphology finding [Identifier] in Blood

113

4.69

22.47

3.8

3.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

112

409

2.84

22.33

2.7

3.0

3.11

3.46

g/l

1.84

112

384

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

236

4231

0.50

22.14

1.6

1.36

1.40

mmol/l

0.27

197

3567

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

287

3.20

22.06

2.1

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

7.79

21.70

2.3

2.4

325.33

347.78

e6/l

0.07

(3026782) Osmolality of Urine

450

2866

1.73

21.41

2.9

2.6

538.07

546.56

mosm/kgh2o

0.36

398

2419

(3012501) Base excess in Blood by calculation

303

3.10

21.38

3.6

4.3

2.37

2.54

mmol/l

0.25

188

(3023183) Ammonium ion [Moles/volume] in Plasma

307

3.05

20.91

1.6

3.1

28.06

37.44

umol/l

2.26

280

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

142

4.10

20.73

1.7

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

6.23

20.67

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

180

854

2.21

20.54

1.7

1.6

—

(3010421) pH of Blood

102

371

2.84

20.49

3.4

4.0

7.42

0.18

327

(3025159) Blasts/100 leukocytes in Blood

203

1019

2.10

20.06

4.5

4.0

0.10

0.04

0.60

109

204

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

299

3.03

19.98

2.0

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

319

1882

1.82

19.60

5.2

5.7

1.01

1.04

mmol/l

1.12

304

1736

(3031040) Bacteria [#/volume] in Urine by Automated count

1203

9828

1.53

19.47

4.5

4.1

2881.26

1895.48

e6/l

0.17

144

(3036489) Thrombin time

130

552

2.45

19.16

2.5

20.87

21.26

0.42

119

488

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

254

3.15

19.04

2.5

2.2

34.44

32.40

u/ml

0.03

206

(3021879) Hepatitis B virus core Ab [Presence] in Serum

206

1063

2.04

18.87

1.4

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

205

3.40

18.81

2.2

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

104

400

2.68

18.80

1.8

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

285

2.99

18.51

2.1

2.3

16.99

16.84

0.10

149

(40768795) Lymph node Pathology biopsy report

13.66

18.24

1.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

4.73

18.01

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

149

3.76

17.85

1.6

1.5

283.96

279.26

mosm/kgh2o

0.74

106

(1761868) Lipid panel - Serum or Plasma

394

5773

0.61

17.16

2.6

2.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

198

1052

1.98

16.67

3.0

2.4

8.69

10.74

g/l

12.13

185

967

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

264

2.95

16.63

1.6

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

178

3.38

16.33

2.1

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

114

512

2.30

14.83

2.1

1.8

1.00

1.49

ug/l

0.39

447

(3000850) Epithelial cells [#/volume] in Urine

439

3024

1.57

14.69

2.8

2.4

5.44

5.61

e6/l

0.08

405

2686

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

25.22

14.68

1.5

2.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

243

1436

1.78

14.65

5.6

3.7

5.71

5.85

kpa

1.64

234

1387

(3000963) Hemoglobin [Mass/volume] in Blood

1681

18094

0.62

14.56

38.5

17.5

133.26

137.63

g/l

27.66

1666

17793

(3020682) Albumin/Creatinine [Ratio] in Urine

333

4921

0.61

14.50

3.5

3.9

10.61

8.31

mg/mmol

0.32

192

3163

(3010813) Leukocytes [#/volume] in Blood

1681

18089

0.63

14.44

38.0

17.5

6.98

6.73

e9/l

4.81

1636

17512

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

257

1550

1.75

14.43

2.7

2.6

6.45

7.85

umol/l

0.79

217

1331

(3026361) Erythrocytes [#/volume] in Blood

1681

18088

0.63

14.41

38.0

17.5

4.40

4.56

e12/l

31.03

1634

17506

(3035941) MCH [Entitic mass]

1681

18087

0.63

14.38

37.9

17.4

30.60

30.32

8.87

1662

17787

(3024731) MCV [Entitic volume]

1681

18086

0.63

14.36

38.0

17.4

91.36

90.79

6.11

1664

17786

(3035637) Corticotropin [Mass/volume] in Plasma

149

3.41

14.14

1.6

1.5

—

(3012516) Albumin [Mass/volume] in Urine

315

4691

0.61

14.10

2.9

3.3

904.09

213.55

mg/l

0.98

197

3055

(3007461) Platelets [#/volume] in Blood

1681

18073

0.63

14.04

38.0

17.5

239.10

248.48

e9/l

6.18

1637

17553

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

15.86

13.92

1.3

4.1

—

(3009508) Creatinine [Moles/volume] in Urine

349

5062

0.63

13.91

3.0

3.3

8.14

7.85

mmol/l

0.46

285

4330

(3009542) Hematocrit [Volume Fraction] of Blood

1680

18058

0.63

13.87

38.3

17.6

39.56

40.93

5.04

1581

16813

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

138

3.46

13.60

2.2

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

119

3.67

13.59

1.8

1.5

—

(3002032) Base excess in Venous blood by calculation

238

1428

1.75

13.58

5.7

3.7

2.09

1.99

mmol/l

0.20

206

1177

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

642

4859

1.47

13.58

5.0

2.8

31.20

35.84

u/l

0.72

619

4612

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

211

2.95

13.50

1.8

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

211

2.95

13.50

1.8

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

137

2540

0.51

13.45

1.2

6.71

10.59

u/ml

0.43

997

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

212

2.93

13.39

1.6

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

146

760

1.99

13.02

6.4

4.1

24.87

24.17

mmol/l

2.45

140

743

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

16.82

12.98

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

170

933

1.90

12.97

1.9

1.6

—

(1616796) Gas panel - Central venous blood

303

2.57

12.85

3.1

3.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

751

5910

1.42

12.68

3.7

3.6

34.14

60.26

ng/l

1.59

572

4003

(3009214) Lutropin [Units/volume] in Serum or Plasma

417

2.31

12.61

2.4

1.5

6.11

7.70

u/l

0.94

339

(3042111) Morphology [Interpretation] in Bone marrow Narrative

163

3.12

12.27

1.6

1.3

—

(3020891) Body temperature

121

602

2.07

12.22

6.1

4.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

230

2.75

12.10

1.4

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

385

2.31

11.76

1.4

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

108

523

2.12

11.72

2.2

1.4

20.80

24.21

iu/l

0.54

442

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

112

3.53

11.70

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

430

3091

1.49

11.51

3.2

3.8

117.90

589.02

ng/l

6.64

331

2407

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

154

3.10

11.46

1.6

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

200

1204

1.73

11.24

5.7

3.3

4.79

4.62

kpa

0.46

193

1157

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

160

2.98

10.75

1.7

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

160

2.98

10.75

1.7

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

866

10266

0.73

10.70

2.9

3.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

159

2645

0.57

10.66

1.2

1.3

26.76

35.22

iu/ml

0.52

842

(3037121) Protein [Mass/volume] in Urine

102

502

2.09

10.63

5.1

3.5

0.18

0.28

g/l

2.13

195

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

8.01

10.59

1.3

1.6

—

(3002256) Pathology report gross observation

190

1147

1.72

10.57

1.3

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.66

10.48

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

228

1449

1.64

10.45

4.5

3.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

+∞

10.42

1.1

0.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.45

10.40

2.6

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.16

10.31

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

135

3.08

9.95

1.3

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

256

1697

1.58

9.86

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

182

2.73

9.60

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

330

2.26

9.44

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

330

2.26

9.44

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.71

9.44

1.1

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

17.61

9.40

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1328

14635

0.74

9.17

4.5

1.73

2.09

mu/l

2.54

1225

13420

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.44

9.08

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.44

9.08

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

3.52

9.08

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

409

2.10

9.05

2.4

3.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

7.06

9.02

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.41

8.91

2.3

1.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

7.98

8.85

2.0

1.1

57.45

52.00

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

171

1057

1.67

8.72

5.9

2.9

1.22

1.23

mmol/l

1.30

160

890

(3042936) Bacteria identified in Isolate by Culture

289

2021

1.50

8.69

1.8

2.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

8.34

1.4

0.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.71

8.18

1.9

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.87

7.97

1.0

—

(40758292) HTLV I+II Ab panel - Serum

13.07

7.87

1.4

1.1

—

(3051651) Icteric interference index of Serum or Plasma

3.41

7.80

5.0

3.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

2.64

7.64

1.8

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

106

1803

0.57

7.61

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.82

7.53

2.0

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.92

7.43

1.2

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

3.92

7.43

1.6

3.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.76

7.36

2.0

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

167

1082

1.59

7.08

2.1

2.4

10.88

22.94

au/ml

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

10.05

7.03

1.2

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

170

2.50

7.02

2.0

1.5

0.22

0.34

nmol/l

1.77

147

(40768793) Breast Pathology biopsy report

3.11

7.02

1.3

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

7.00

6.99

2.4

1.7

0.23

0.11

nmol/l

0.47

(3052851) Hemolysis interference index of Serum or Plasma

429

1.92

6.98

3.9

3.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

524

1.83

6.92

1.8

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.55

6.90

1.1

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

3.73

6.64

3.3

6.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

308

2.04

6.42

1.3

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

226

1602

1.46

6.31

3.0

2.5

1.84

1.73

0.88

204

1404

(3007853) Bacteria identified in Skin by Aerobe culture

245

1769

1.44

6.21

1.5

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

167

1116

1.54

6.21

1.8

2.2

0.24

0.21

g/l

4.91

158

1016

(21494755) Public health laboratory ask at order entry panel

1606

0.59

6.11

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

134

2.56

6.04

1.4

1.3

1.02

1.37

promille

0.60

101

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

10.05

6.03

1.2

—

(3021901) Oxygen saturation in Capillary blood

263

2.08

5.92

2.4

3.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.70

5.92

1.2

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

15.05

5.90

8.4

1.0

18.07

14.02

u/ml

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

231

2.15

5.84

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1169

10574

1.24

5.49

4.4

4.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

145

968

1.54

5.44

3.6

4.8

1.97

1.70

mmol/l

0.47

117

694

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1022

0.53

5.39

1.3

1.4

—

(40765096) Chromosome analysis panel by Banding

6.22

5.38

1.1

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

137

2.43

5.30

4.4

3.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

5.21

1.0

0.0

—

(3051593) INR in Capillary blood by Coagulation assay

2.95

5.14

2.5

11.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

299

1.93

5.14

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

128

1891

0.66

5.09

2.4

2.5

228.91

148.62

ug/g

0.67

109

1511

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

110

700

1.60

5.09

3.6

2.7

1.15

1.24

0.66

110

695

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

282

2156

1.36

5.09

1.5

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

5.68

5.06

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.37

5.06

6.7

1.3

—

(3009343) pH of Capillary blood

147

1001

1.50

5.04

3.7

4.8

7.44

7.41

2.42

105

(3042631) Mycobacterium sp identified in Specimen

147

2.33

5.02

2.0

3.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

101

1564

0.63

5.00

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

540

1.68

4.98

2.5

1.7

397.37

296.37

mu/l

1.10

491

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.03

4.91

1.1

—

(40768800) Prostate Pathology biopsy report

2.96

4.71

1.3

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

267

1.93

4.65

3.9

3.4

4.91

4.13

e9/l

0.95

267

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

178

1283

1.42

4.58

2.0

2.3

35.87

74.91

u/l

0.52

149

1086

(3024928) Oxygen saturation in Venous blood

320

1.84

4.52

4.1

2.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

344

2752

1.30

4.52

1.6

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

5.24

4.45

1.4

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1106

12039

0.83

4.44

4.1

3.8

14.70

14.76

pmol/l

0.29

1023

10982

(3028026) IgM [Mass/volume] in Serum or Plasma

123

831

1.51

4.41

2.4

1.5

1.42

1.17

g/l

0.50

118

763

(3023520) Reticulocytes [#/volume] in Blood

162

1157

1.43

4.39

2.6

2.4

73.26

69.39

e9/l

0.63

121

868

(3013707) Erythrocyte sedimentation rate by Westergren method

1056

11538

0.83

4.38

3.7

4.0

11.53

11.05

mm/h

0.51

989

10694

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

274

1.88

4.33

4.9

3.5

60.08

57.05

0.70

274

(3001019) Free T4 and TSH panel - Serum or Plasma

777

0.52

4.33

1.2

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

569

1.61

4.33

2.2

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.97

4.29

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

178

2.10

4.27

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

461

0.39

4.24

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

101

1507

0.65

4.24

1.6

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

124

847

1.49

4.23

2.8

3.0

4.19

4.58

pmol/l

3.18

115

739

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

284

1.85

4.21

1.3

1.5

83.13

102.27

u/ml

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

569

6581

0.81

4.19

2.4

2.8

187.83

117.72

ug/l

2.52

523

6075

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.43

4.18

2.1

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

149

2053

0.70

4.11

1.6

1.8

1.85

1.47

2.51

126

1829

(40761511) CBC panel - Blood by Automated count

1601

16756

0.80

4.05

21.0

11.4

—

(3014271) Vancomycin [Susceptibility]

2.73

3.92

2.8

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

1012

0.60

3.88

1.4

1.3

385.34

258.76

u/ml

0.45

936

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.80

3.87

1.2

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

376

4508

0.80

3.82

3.4

3.5

22.87

24.07

0.72

170

1955

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

484

5640

0.81

3.76

3.8

3.5

2.72

1.86

ug/l

1.26

432

5072

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

276

3424

0.78

3.74

1.2

1.3

2.32

1.76

u/ml

0.23

926

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

209

1.93

3.73

1.6

2.0

—

1226.67

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

148

2.11

3.69

1.3

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.80

3.69

4.4

3.1

1.17

1.70

ug/l

0.36

(3014148) Varicella zoster virus Ab [Titer] in Serum

203

1.94

3.68

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.69

3.67

1.8

5.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

427

0.42

3.59

1.2

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

584

0.51

3.50

1.3

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.63

3.49

1.2

2.5

21.27

18.34

umol/l

0.34

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1648

17136

0.81

3.46

18.4

8.6

31.64

26.93

u/l

14.40

1619

16479

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

224

2826

0.77

3.45

1.4

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.56

3.43

1.8

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.53

3.40

2.2

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.53

3.40

2.2

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.53

3.40

2.2

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

107

2.26

3.39

2.2

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

107

2.26

3.39

2.2

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

107

2.26

3.39

2.2

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

328

1.70

3.38

1.9

2.1

131.64

133.42

g/l

0.18

245

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.02

3.37

1.9

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

627

0.53

3.35

1.3

1.7

2.58

4.79

mg/l

1.32

448

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

675

1.47

3.28

4.7

3.6

51.32

48.53

0.54

663

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

156

2.00

3.25

2.6

2.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1007

0.64

3.14

1.2

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

446

1.57

3.11

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

4.51

3.11

1.1

1.8

—

(3000494) Fungus identified in Specimen by Culture

218

1727

1.29

3.10

1.5

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

548

6214

0.84

3.08

2.2

2.3

72.90

76.48

nmol/l

2.40

504

5549

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

7.52

3.05

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.85

3.02

1.0

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

557

6292

0.84

2.97

1.8

1.9

94.71

94.99

pmol/l

0.05

311

3281

(3028433) Virus identified in Specimen by Culture

2.70

2.89

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.68

2.87

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

6.68

2.87

1.0

—

(40761536) Microorganisms panel - Urine sediment

156

1197

1.33

2.82

4.3

3.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.78

2.81

1.2

1.0

95.67

88.62

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1654

17120

0.83

2.80

30.0

13.4

71.74

78.16

umol/l

15.96

1654

17114

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.65

2.79

2.2

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.65

2.79

2.2

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.58

2.78

1.8

1.5

—

(3019225) pH of Specimen

178

1394

1.30

2.78

3.7

3.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

207

0.34

2.78

1.3

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

135

1769

0.75

2.76

1.8

2.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1120

10448

1.16

2.75

3.7

3.0

62.80

45.35

u/l

3.46

1063

9727

(3016244) Insulin [Units/volume] in Serum or Plasma

105

2.11

2.69

2.8

3.7

20.76

24.61

mu/l

0.19

(3022145) Colonoscopy Study observation

110

1479

0.73

2.67

1.2

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

381

4404

0.83

2.61

2.8

3.1

773.31

1440.86

ng/l

7.04

343

3735

(3020393) Adenovirus Ag [Presence] in Stool

3.34

2.60

1.4

1.9

—

(40768797) Stomach Pathology biopsy report

161

2041

0.77

2.59

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

121

1594

0.74

2.58

1.7

2.0

—

(3022475) Manganese [Moles/volume] in Blood

7.15

2.55

1.4

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

157

1227

1.30

2.51

2.6

2.3

11.67

14.39

nmol/l

4.28

139

1102

(4200892) Spirometry reversibility

1098

0.70

2.51

1.3

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

348

4042

0.83

2.51

3.2

2.4

4449.29

5504.38

umol/l

0.19

316

3545

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.39

2.47

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.39

2.47

1.0

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

267

3175

0.82

2.46

2.6

2.5

0.74

0.70

ug/l

0.43

176

1971

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

2.40

0.0

1.2

—

0.07

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

280

0.43

2.40

1.3

1.1

1.68

1.60

u/ml

—

135

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

149

1886

0.77

2.38

3.6

4.6

31.75

32.31

0.29

115

1300

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.26

2.37

1.0

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.62

2.36

1.2

1.1

89.92

101.63

0.70

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.62

2.36

1.2

1.0

95.40

86.78

—

(3000492) Spirometry study

118

1537

0.75

2.34

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

609

0.62

2.32

1.5

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

126

1.92

2.31

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

247

0.40

2.30

2.0

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

315

0.47

2.29

1.3

1.1

7.02

2.09

u/ml

—

178

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.90

2.25

1.1

—

(4146454) Self-monitoring of blood glucose

182

0.38

2.15

2.4

2.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

280

0.46

2.14

1.2

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

650

1.37

2.10

1.5

2.0

34.10

39.09

u/l

1.90

566

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.91

2.07

1.2

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

2.06

0.0

1.0

—

(3011648) Oxygen content in Venous blood

125

1.85

2.02

6.3

2.4

12.55

11.47

0.43

125

(3021788) Differential panel - Synovial fluid

286

0.49

2.01

1.8

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.82

2.00

1.2

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

412

0.58

1.96

1.6

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.34

1.96

1.9

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.34

1.96

1.0

1.2

—

(3003338) MCHC [Mass/volume]

1343

14000

0.88

1.93

34.0

15.5

334.64

333.33

g/l

5.44

1334

13881

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.12

1.92

1.1

1180.40

1658.96

miu/ml

0.78

(3008898) HLA-B27 [Presence]

568

0.65

1.92

1.0

1.1

—

(3013512) EKG study

481

4319

1.15

1.90

3.9

3.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

155

0.39

1.89

1.5

1.4

70.40

231.99

pmol/l

—

155

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

719

0.69

1.88

1.5

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.65

1.86

1.4

1.6

—

(21494434) Karyotype in Bone marrow

100

1.91

1.85

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

367

1.46

1.85

2.4

2.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

146

1181

1.25

1.84

3.7

2.2

71.43

68.29

ml/min/173m2

0.30

446

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.54

1.84

1.3

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

900

0.72

1.83

1.5

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

165

1996

0.81

1.83

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

335

3803

0.86

1.82

2.0

2.2

2.97

2.87

mg/l

0.27

284

3222

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.05

1.80

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.05

1.80

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.05

1.80

1.4

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

328

1.47

1.80

1.3

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

362

1.45

1.78

3.7

4.1

—

(3037522) Nuclear Ab [Titer] in Serum

176

2104

0.82

1.74

1.2

1.3

528.28

558.23

titre

0.07

451

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

1.68

0.0

1.1

—

36.72

—

(3000012) Reticulocyte production index

164

1.65

1.68

2.1

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

126

1.75

1.68

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

172

1.64

1.67

3.5

2.3

—

(3035933) Granulocytes/100 leukocytes in Blood

2.51

1.66

1.1

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.51

1.66

1.3

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

278

1.48

1.62

1.4

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.15

1.61

1.3

1.6

—

1903858.33

iu/ml

—

(3037756) Immunofixation for Serum or Plasma

230

1.53

1.60

1.5

1.2

—

(3036180) Methadone [Presence] in Urine

1.95

1.59

2.9

2.0

—

(3008037) Lactate [Moles/volume] in Venous blood

329

1.44

1.59

4.9

2.7

1.59

1.60

mmol/l

0.03

314

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.01

1.58

1.2

2.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

309

3482

0.87

1.53

1.5

18.77

20.23

nmol/l

1.05

274

2953

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

815

0.74

1.53

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

126

0.40

1.49

1.0

1.3

8.96

8.70

mmol/l

—

121

(3022313) Gas panel - Capillary blood

760

1.28

1.49

4.2

5.1

—

(3044889) 12 lead EKG panel

1147

10958

1.10

1.47

3.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

203

1.54

1.46

1.4

1.3

0.65

0.66

nmol/l

0.03

193

(3044941) Cell count panel - Synovial fluid

254

0.55

1.46

1.5

—

(3019150) Specific gravity of Urine by Refractometry

307

3448

0.87

1.45

3.8

1.02

kg/l

0.38

494

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

297

3343

0.87

1.45

1.6

1.7

46000489.89

49122601.66

pmol/l

0.02

250

2791

(3000330) Specific gravity of Urine by Test strip

737

1.27

1.44

3.9

3.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

508

1.33

1.44

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.31

1.43

1.6

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

351

0.62

1.42

1.2

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.18

1.40

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.18

1.40

1.4

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

121

0.41

1.37

17.6

15.2

542.60

807.75

nmol/l

—

115

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

124

0.40

1.36

45.8

19.6

1061.20

1426.39

nmol/l

—

119

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

159

1.58

1.34

1.6

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.92

1.33

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.92

1.33

1.3

1.6

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.97

1.32

1.1

1.3

4.88

4.70

umol/l

0.05

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

152

1.59

1.32

1.6

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

153

1.58

1.29

1.6

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

131

0.46

1.28

1.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.94

1.27

1.3

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

134

0.45

1.27

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

552

0.72

1.27

1.8

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1636

15969

1.12

1.27

26.4

12.1

20.57

22.90

mg/l

2.90

1523

12255

(40757373) Influenza virus identified in Isolate

2.29

1.27

1.4

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

154

1.56

1.26

1.6

1.3

—

(3022621) pH of Urine by Test strip

117

971

1.22

1.24

3.2

2.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

374

0.66

1.23

1.6

—

(3016750) Collection duration of Urine

1.73

1.21

2.2

2.0

526.73

502.54

min

0.67

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

156

1.54

1.20

1.6

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

306

1.38

1.20

5.2

2.8

7.15

7.43

mmol/l

0.34

293

(3016650) Hepatitis A virus Ab [Presence] in Serum

247

1.42

1.19

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.50

1.15

2.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

482

0.72

1.12

1.5

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

310

1.36

1.12

1.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

184

1.47

1.11

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

628

0.76

1.11

1.1

—

1.62

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.38

1.09

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

163

0.55

1.08

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

227

1.42

1.08

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

385

0.70

1.07

1.1

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

313

1.35

1.07

1.4

257.81

244.76

u/ml

0.07

188

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

326

0.67

1.07

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

325

0.67

1.05

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

324

0.68

1.04

1.2

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

203

0.59

1.03

1.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

323

0.68

1.03

1.2

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.92

1.02

1.4

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

163

1424

1.16

1.00

2.1

2.4

4.53

7.99

ug/l

4.51

145

1257

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

180

1.45

1.00

1.3

1.2

—

nmol/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

273

0.66

0.99

1.2

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

188

0.58

0.99

1.2

—

(1002224) Polysomnography panel

704

0.79

0.97

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

232

1.39

0.97

1.1

1.2

4.67

5.60

u/ml

0.16

107

(3026389) Candida sp identified in Specimen by Organism specific culture

173

1.45

0.97

1.9

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

241

1.38

0.96

1.0

1.1

—

(3004451) EKG impression Narrative

1.74

0.96

1.2

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.96

0.0

1.1

—

52.99

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

234

0.64

0.94

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

303

1.33

0.94

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

158

1.46

0.93

1.6

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.72

0.92

1.1

1.2

—

4.29

iu/ml

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

266

0.67

0.89

1.2

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

104

0.48

0.89

2.2

2.0

3.00

3.24

ug/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

230

0.65

0.89

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

103

1.56

0.87

1.3

2.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.72

0.86

2.2

2.5

—

(3005033) Fetal Nuchal fold Thickness US

263

0.68

0.85

1.2

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

332

0.72

0.84

1.1

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.94

0.84

1.0

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

109

939

1.17

0.84

2.7

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

126

1101

1.15

0.81

3.4

1.5

65.46

67.13

g/l

1.34

113

995

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

437

1.24

0.80

2.3

2.1

2044.92

3233.69

u/l

0.25

192

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

407

0.76

0.79

2.6

2.2

160.29

109.46

ug/min

0.23

261

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.67

0.78

1.9

1.7

179.55

195.92

u/l

0.50

(3044927) Protein electrophoresis panel - Urine

163

0.61

0.78

1.3

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

612

1.20

0.78

1.9

1.7

1.74

1.47

g/l

1.35

522

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

385

1.25

0.77

3.1

1.5

41.37

34.66

mg/l

0.24

313

(3034860) Kappa light chains.free [Mass/volume] in Serum

386

1.25

0.76

3.1

1.5

38.43

43.55

mg/l

0.33

315

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.70

0.75

3.2

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

1.64

0.73

1.7

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.00

0.72

3.4

8.0

—

(3004775) Volume in Urine collected for unspecified duration

125

1.44

0.72

2.2

2.4

610.25

628.86

0.13

(3047189) Immunofixation for 24 hour Urine

1.80

0.72

1.3

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.80

0.72

2.3

2.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1458

14866

0.94

0.72

24.1

10.7

89.56

81.95

ml/min/173m2

35.28

1279

11964

(3004716) Salmonella sp identified in Stool by Organism specific culture

794

0.84

0.71

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

229

0.70

0.71

1.5

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.93

0.70

1.0

1.2

108.60

93.96

—

(3011288) Drugs identified in Urine by Screen method

432

0.78

0.70

1.8

3.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.64

0.68

1.4

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

136

1.40

0.66

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.53

0.66

1.2

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.79

0.66

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

121

1.41

0.62

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.55

0.62

1.0

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

466

0.81

0.60

1.3

118.00

233.06

miu/ml

1.13

206

(3039162) Centromere protein B Ab [Units/volume] in Serum

186

0.70

0.59

1.1

1.3

—

46.51

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.6

—

143.60

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

114

1.41

0.59

1.2

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

197

0.71

0.59

1.1

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

989

0.87

0.58

1.2

196.12

140.38

iu/ml

0.31

389

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.58

0.0

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.72

0.57

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.48

0.57

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

283

1.24

0.57

3.6

1.4

—

(3024263) Appearance of Synovial fluid

0.57

0.56

1.4

1.5

—

(3006462) Nitrate [Presence] in Urine

1.54

0.55

3.2

3.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

562

5857

0.94

0.55

4.0

3.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

122

0.65

0.54

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

122

0.65

0.54

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

122

0.65

0.54

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

125

0.64

0.54

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

125

0.64

0.54

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

125

0.64

0.54

1.0

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

488

1.17

0.53

1.1

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

1.45

0.53

1.3

1.1

133.11

83.96

u/l

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

1.43

0.52

1.3

1.1

36.11

22.25

u/l

—

(4281824) Cell count and differential, peritoneal fluid

1.41

0.51

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

242

1.24

0.51

1.1

1.2

1.25

4.47

u/ml

—

(36660697) Celiac disease serology panel - Serum

113

1248

0.90

0.49

1.1

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1664

16447

1.06

0.48

29.3

14.1

138.92

139.72

mmol/l

22.49

1645

15986

(3036603) Volume of Urine

1.45

0.48

1.3

1.4

1950.55

1873.31

0.12

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.41

0.47

2.9

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

280

2962

0.94

0.46

1.7

1.3

2.20

2.47

g/l

0.81

185

1791

(3045414) Leukocytes [Presence] in Urine

618

1.14

0.46

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

350

3330

1.06

0.46

1.9

1.8

1.95

1.21

mg/l

1.75

285

2493

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

117

0.68

0.46

1.5

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.43

0.45

1.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1073

0.90

0.45

2.9

4.1

86.35

89.50

ng/l

0.11

945

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

174

1.27

0.45

2.2

1.5

—

(40768806) Pleura Pathology biopsy report

1.40

0.44

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.37

0.44

1.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

127

0.71

0.43

1.2

1.1

—

49.33

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.56

0.42

1.0

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

131

1.30

0.42

1.8

1.86

2.06

g/24h

—

(4062490) Immunoglobulin typing, IgG

149

1.28

0.41

1.3

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

434

0.85

0.41

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.41

0.0

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.41

0.0

1.4

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

23.60

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

29.00

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.4

—

(3006653) Thiamine [Moles/volume] in Blood

1.39

0.40

1.0

1.3

129.00

148.87

nmol/l

0.58

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

259

1.20

0.40

1.3

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

635

0.88

0.40

2.4

2.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

271

0.81

0.40

1.3

1.1

—

11.89

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.33

0.40

1.4

2.0

0.91

8.15

nmol/l

—

(3012565) Volume of 24 hour Urine

1.33

0.40

2.0

2.1

2358.75

2055.17

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

150

1.27

0.40

1.3

1.4

0.37

0.36

g/l

0.06

111

(3027135) IgG subclass 1 [Mass/volume] in Serum

150

1.27

0.40

1.3

1.4

6.35

6.88

g/l

0.25

111

(3028192) IgG subclass 2 [Mass/volume] in Serum

150

1.27

0.40

1.3

1.4

2.53

2.91

g/l

0.38

109

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.40

0.0

1.2

—

6.23

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.40

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.40

0.0

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.2

—

330.12

—

(3023420) DNA double strand Ab [Units/volume] in Serum

171

0.76

0.39

1.0

1.5

—

27.89

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

723

1.11

0.38

3.0

2.7

0.39

0.22

e6/l

0.34

700

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.35

0.38

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

113

0.71

0.37

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.35

0.37

1.0

1.2

280.20

244.92

pmol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

116

0.69

0.37

1.5

1.2

—

(3017569) Oxygen content in Arterial blood

1.39

0.37

1.1

1.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

135

0.74

0.36

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1.34

0.35

2.5

2.9

55675.00

40706.03

ug/l

0.48

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

199

1879

1.07

0.35

2.2

2.6

25.21

23.63

0.65

171

1622

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

125

1345

0.92

0.35

2.0

3.2

100.47

216.61

ng/l

8.93

111

1239

(3023419) Bacteria identified in Sputum by Culture

236

1.19

0.35

1.8

3.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.37

0.34

1.0

1.1

—

(3019977) pH of Arterial blood

1.37

0.34

1.2

2.4

7.44

—

(3015736) pH of Urine

598

6147

0.96

0.34

3.4

3.2

6.03

5.84

0.85

428

(3009261) Glucose [Presence] in Urine by Test strip

777

7596

1.04

0.33

3.7

3.4

0.00

0.01

estimate

1.08

160

1263

(3016879) Cocaine [Presence] in Urine

593

0.89

0.33

2.5

2.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

198

0.81

0.32

1.1

1.45

g/l

0.03

177

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

408

1.13

0.31

2.7

1.4

0.08

0.02

g/l

0.36

374

(3025130) Human papilloma virus identified in Specimen

164

0.79

0.30

1.2

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1664

16504

1.04

0.30

28.9

14.2

3.95

3.98

mmol/l

7.57

1642

16014

(1001926) Buprenorphine [Presence] in Urine by Screen method

505

0.89

0.30

2.7

2.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

259

1.16

0.30

1.5

2.1

5.13

5.51

mmol/24h

0.18

223

(3019832) Treponema pallidum Ab [Presence] in Serum

148

1395

1.07

0.29

1.3

1.7

—

(3028300) Cannabinoids [Presence] in Urine

640

0.90

0.29

2.5

2.3

—

(3027944) Amphetamines [Presence] in Urine

629

0.90

0.29

2.4

2.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

217

0.83

0.29

1.1

3.42

2.21

u/ml

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

371

3587

1.04

0.29

3.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

383

1.13

0.28

2.9

1.4

0.00

g/l

-0.00

350

(3027008) Opiates [Presence] in Urine

638

0.91

0.28

2.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

167

1.20

0.28

1.2

1.1

—

(4034850) Laboratory test

564

0.90

0.28

8.1

8.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

168

1.19

0.27

1.1

102.55

95.60

0.61

161

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

489

0.90

0.26

1.7

1.6

0.00

0.20

iu/ml

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.69

0.26

1.0

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

373

0.88

0.26

1.4

1.9

5.03

4.71

iu/l

0.06

136

(3003327) Ova and parasites identified in Stool by Light microscopy

509

0.90

0.26

1.9

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

768

7539

1.03

0.26

3.7

3.4

0.01

0.00

estimate

0.26

176

1402

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

758

0.92

0.25

2.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

445

1.10

0.24

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

379

1.11

0.24

2.9

1.4

0.00

g/l

-0.00

349

(3051387) C reactive protein [Mass/volume] in Capillary blood

341

1.12

0.23

3.3

3.4

31.43

25.99

mg/l

0.22

215

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

443

0.90

0.23

1.1

1.3

—

6.42

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

516

1.09

0.22

2.4

1.4

10.70

10.50

g/l

0.10

455

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

7.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.2

—

(40761535) Cells panel - Urine sediment

123

1293

0.95

0.21

3.3

3.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.16

0.21

6.2

7.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

10.29

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

117

1.20

0.20

1.9

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.23

0.20

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

469

0.92

0.20

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

115

0.78

0.20

1.2

1.5

0.81

0.97

g/l

—

115

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.21

0.19

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

510

1.08

0.19

2.5

1.4

2.81

2.94

g/l

0.66

450

(40768443) Skin Pathology biopsy report

561

0.93

0.19

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

434

1.08

0.18

2.7

1.4

37.93

g/l

0.00

374

(3025941) Bacteria identified in Stool by Culture

815

1.06

0.17

1.3

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

231

2243

1.03

0.17

2.1

2.5

14.02

13.61

umol/l

0.32

215

2084

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.11

0.17

1.0

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

451

4597

0.98

0.17

2.5

2.3

54.22

59.80

u/l

2.40

425

4220

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

129

1.16

0.17

3.9

2.6

1.86

1.91

u/field

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

167

1.14

0.17

2.4

2.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

567

0.93

0.16

1.7

1.8

39.72

39.01

nmol/l

0.09

546

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

282

1.10

0.16

1.5

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

762

7523

1.02

0.16

5.2

4.6

0.00

estimate

-0.00

164

1316

(3002385) Erythrocyte distribution width [Ratio]

1391

13817

1.02

0.16

33.0

14.1

14.36

15.07

1.41

1380

13527

(3014765) Yersinia sp identified in Stool by Organism specific culture

462

0.93

0.15

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

150

0.87

0.14

2.5

4.0

—

(3028707) Methadone [Presence] in Urine by Screen method

285

1.09

0.14

3.4

3.0

—

(3000034) Microalbumin [Mass/volume] in Urine

139

0.86

0.14

2.7

3.2

11.08

24.98

mg/l

—

107

(3019309) Folate [Moles/volume] in Red Blood Cells

283

2892

0.98

0.14

1.6

1.7

1064.45

1174.65

nmol/l

1.54

222

2196

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.82

0.13

1.3

1.5

1.56

1.53

g/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

242

0.91

0.13

1.2

—

(3017732) Neutrophils [#/volume] in Blood

104

1002

1.04

0.12

3.6

2.9

4.72

5.12

e9/l

0.17

800

(3045683) HLA typing for celiac disease panel - Blood or Tissue

104

1.15

0.12

1.0

—

(3012441) Differential panel - Pleural fluid

104

1.15

0.12

1.4

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

399

4052

0.98

0.12

3.9

3.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

446

0.94

0.12

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.16

0.11

1.3

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

240

0.92

0.11

3.1

3.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

209

2044

1.03

0.11

2.1

2.5

2.30

2.33

g/l

0.43

197

1894

(3000570) Elastase.pancreatic [Mass/mass] in Stool

393

0.94

0.10

1.2

1.4

281.09

308.71

ug/g

0.40

234

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.09

0.09

6.2

7.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.04

0.09

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.04

0.09

2.2

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.07

0.08

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

407

4024

1.01

0.08

4.0

3.7

0.00

estimate

0.88

154

1275

(40768441) Liver Pathology biopsy report

0.84

0.07

1.0

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.86

0.07

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

201

1978

1.02

0.07

9.9

6.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.87

0.07

1.1

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

458

0.96

0.07

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.88

0.06

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

218

1.06

0.05

1.3

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

414

0.97

0.05

1.2

1.3

51.25

96.10

titre

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

456

1.03

0.04

2.7

1.4

1.46

0.41

g/l

1.16

396

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

546

1.03

0.04

2.4

1.4

7.46

7.42

g/l

0.07

486

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

546

1.03

0.04

2.4

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

546

1.03

0.04

2.4

1.4

3.58

3.72

g/l

0.40

486

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.10

0.04

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.10

0.04

1.2

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

241

0.95

0.04

2.0

2.3

—

5.20

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

270

1.04

0.03

1.0

1.1

1.00

120.13

iu/ml

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

128

0.94

0.02

1.2

1.0

291.25

281.79

mg/l

0.18

115

(44813793) Dust mix specific IgE antibody measurement

1.08

0.02

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

127

0.94

0.01

1.0

1.6

91.83

87.87

umol/l

0.12

127

(3032773) Endomysium IgG Ab [Titer] in Serum

133

1.05

0.01

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

247

0.97

0.01

1.0

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

236

0.97

0.00

1.3

1.8

0.43

0.91

g/l

2.77

187

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.05

0.00

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

209

1.00

0.00

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

261

1.00

0.00

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

428

1.00

0.00

3.4

1.7

—

(3045788) Cell count panel - Pleural fluid

107

1.03

0.00

1.2

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.00

0.00

4.6

5.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.60

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

2.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.2

—

409.20

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3035880) pH of Pleural fluid

0.97

0.00

1.3

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

-0.00

0.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.00

-0.00

1.0

1.3

162.67

171.48

mmol/24h

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3017704) Immunofixation for Urine

0.95

-0.00

1.0

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.92

-0.00

1.0

1.8

7.93

10.40

ug/l

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.36

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

-0.00

0.0

1.4

—

2.43

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

280.63

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.84

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

0.04

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.5

—

1115.83

—

(3003740) Influenza virus B Ag [Presence] in Specimen

260

1.00

-0.00

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.89

-0.00

1.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.4

—

4.59

—

(3015183) Erythrocyte sedimentation rate

0.96

-0.00

1.3

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

5.3

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BRAIN_WIDE – Malignant neoplasm of brain, including Hilmo

GWS hits: 6

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of brain, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of brain, including Hilmo (C3_BRAIN_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints